Genetic test approved for breast cancer treatment
Thursday 23 June 2011
The US Federal Drugs Administration (FDA) has just approved a genetic test that approves candidates for the breast cancer treatment Herceptin. The test analyses the proteins in breast cancer tumours and identifies which are more responsive to treatment with Herceptin.
>> http://m.foxbusiness.com/quickPage.html?page=19453&content=52820974&pageNum=-1
European Oncology Nursing SocietyAvenue E. Mounier 83
B-1200 Brussels
Belgium
Tel: +32 (0)2 779 9923
Fax: +32 (0)2 779 9937
eons.secretariat@cancernurse.eu